# A Study Comparing Chemotherapy Dosing Based on Either Standard Body Surface Area or Lean Body Mass in Patients With Advanced Lung Cancer

> **NCT01624051** · PHASE2 · UNKNOWN · sponsor: **AHS Cancer Control Alberta** · enrollment: 144 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **OTHER:** Standard dosing method arm: Cisplatin (chemotherapy) dosing based on body surface area
- **OTHER:** Experimental dosing method arm: Cisplatin (chemotherapy) dosing based on individual lean body mass

## Key facts

- **NCT ID:** NCT01624051
- **Lead sponsor:** AHS Cancer Control Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-07
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2014-09-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01624051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01624051, "A Study Comparing Chemotherapy Dosing Based on Either Standard Body Surface Area or Lean Body Mass in Patients With Advanced Lung Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01624051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*